1. Home
  2. VREX vs CTMX Comparison

VREX vs CTMX Comparison

Compare VREX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.77

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.47

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
CTMX
Founded
2016
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.6M
596.2M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
VREX
CTMX
Price
$10.77
$4.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$16.67
$12.10
AVG Volume (30 Days)
248.4K
9.7M
Earning Date
05-07-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$811,000,000.00
$76,201,000.00
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
$27.22
P/E Ratio
$215.60
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$0.40
52 Week High
$14.57
$8.21

Technical Indicators

Market Signals
Indicator
VREX
CTMX
Relative Strength Index (RSI) 32.50 45.62
Support Level $9.81 $3.55
Resistance Level $12.61 $6.20
Average True Range (ATR) 0.37 0.61
MACD 0.01 -0.06
Stochastic Oscillator 33.47 10.29

Price Performance

Historical Comparison
VREX
CTMX

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: